Agraban 5mg Infusion
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Tirofiban (5mg)
Overview Agraban 5mg Infusion
CardioGuard 5mg Infusion is an anticoagulant that inhibits the development of dangerous blood clots. It aids in preventing myocardial infarction in individuals experiencing acute chest pain resulting from reduced coronary blood flow. CardioGuard 5mg Infusion is administered only under strict medical supervision. Dosage and treatment length will be determined by your physician. Continue all other prescribed medications as directed, even after receiving this infusion. Potential side effects include headache, hematoma, nausea, bruising, post-surgical bleeding, and blood in the urine or feces. Report any petechiae or blood in vomit, urine, or stool to your doctor immediately. This medication requires careful consideration for certain patients. Prior to administration, disclose any bleeding disorders, liver or kidney conditions, breastfeeding status, and all other medications currently being taken.
Uses of Agraban 5mg Infusion
Avoiding a heart attack
Major Benefits of Agraban 5mg Infusion:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Agraban 5mg Infusion:
- Headache
- Nausea
- Hematoma
- Ecchymosis (discoloration of the skin resulting from bleeding underneath)
- Postoperative bleeding
- Blood in stool
- Blood in urine
How to use Agraban 5mg Infusion:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Agraban 5mg Infusion works:
A 5mg intravenous dose of Agraban acts as an antiplatelet agent, inhibiting platelet aggregation to reduce the risk of dangerous thrombus development, thus lessening the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Agraban 5mg Infusion is unknown. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The intravenous administration of Agraban 5mg is typically deemed safe for pregnant individuals. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nonetheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Agraban 5mg Infusion to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Inapplicable, since Agraban 5mg Infusion is administered solely within a hospital setting.
KidneyCAUTION
Patients with impaired kidney function require careful monitoring when administered Agraban 5mg Infusion. Dosage modification of Agraban 5mg Infusion may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Agraban 5mg Infusion with close monitoring; dosage modification may be necessary. Severe liver disease contraindicates the use of Agraban 5mg Infusion. Physician consultation is advised.
What if you forget to take Agraban 5mg Infusion :
Omitting a scheduled dose of Agraban 5mg Infusion requires immediate physician consultation.
Facts to Know About Agraban 5mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Phenylalanine-based compounds |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | IIb/IIIa receptor antagonists |
3,018 People bought this recently